Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for VTE prophylaxis in multiple myeloma patients receiving VTD
NCT04106700Phase 2Terminated
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Apr 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in venous thromboembolism (VTE), sponsored by Health Research Institute Hospital La Fe. Started Apr 2019; status: terminated.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04106700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04106700.